Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül
Prospective Evaluation of Physician Modified Endografts for Aortic Disease
A legfontosabb adatok
- Ki végzi
- Mayo Clinic
- Hol
- Jacksonville (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 20 fő, tervezett
- Kezdés
- 2026. júl. 10.
- Várható befejezés
- 2028. júl. 15.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Physician-Modified Terumo Treo Abdominal Stent-Graft System
- A regiszteradat frissítve
- 2026. július 13.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for people aged 50 or older with an aortic aneurysm (a bulge in the main artery) who face high risk with open surgery. It tests the Physician-Modified Terumo Treo Abdominal Stent-Graft System.
- Életkor
- 50 years or older
- Nem
- All sexes
- A betegség stádiuma
- Aneurysm larger than 5.5cm (2,2 in) in males or 5.0cm in females, or growth of more than 0.5 cm (0,2 in) in 6 months, or a saccular aneurysm at significant risk of bursting, or an aneurysm causing symptoms. Type II, III and IV thoracoabdominal extent. High risk with open surgery, for example FEV1 of <1 liter, uncorrectable coronary disease, frailty or hostile abdomen. Artery size and shape must allow the device to be placed.
- Korábbi kezelés
- No prior aortic repair.
A részvétel fő kizáró okai
- Aneurysm can be treated with an approved, marketed device as labeled, or the person can join a manufacturer's study
- Burst (ruptured) aneurysm
- Pregnant or breastfeeding
- Baseline creatinine greater than 2.0 mg/dL (177 µmol/L)
- Allergy to device materials, or to blood thinners or contrast dye that cannot be managed
A regiszter feltételei, szó szerint
Mind a 33 feltétel megnézéseKevesebb
Ki vehet részt
- An aneurysm with a maximum diameter of >5.5cm in males and >5.0cm in females in diameter just proximal to the aneurysm using orthogonal (i.e., perpendicular to the centerline) measurements
- Aneurysm with a history of growth > 0.5 cm in 6 months
- Saccular aneurysm deemed at significant risk for rupture
- Symptomatic aneurysm
- Extent of aorta to be treated: type II, III and IV thoracoabdominal
- Subject is at high-risk of morbidity and mortality with open surgical repair as defined by FEV1 of <1 liter or uncorrectable coronary disease, frailty, hostile abdomen
- Iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices or accessories, with or without use of a surgical conduit
- Non-aneurysmal aortic segment proximal to the aneurysm (neck) with a:
- Minimum neck length of 15mm
- Diameter in the range of 17-32
- Minimum branch vessel diameter greater than 5 mm
- Iliac artery distal fixation site
- An inside diameter of 8mm - 13mm and a length of ≥ 10mm or
- an inside diameter of > 13mm - 20mm and a length of ≥ 15mm
- Age: ≥50 years old
Ki nem vehet részt
- Prior aortic repair
- Patient is eligible for treatment with an FDA-approved marketed device and patient can enroll in a manufacturer-sponsored clinical study at our institution or is willing and eligible to participate in a study with a manufacturer-made device at another institution
- Subject has had a major surgical or interventional procedure unrelated to the treatment of the aneurysm planned < 30 days of endovascular repair
- Known sensitivities or allergies to the materials of construction of the devices, including nitinol, polyester, PTFE, stainless steel, platinum/iridium, tantalum markers
- Known hypersensitivity or contraindication to anticoagulation or contrast media that cannot be adequately medically managed
- Unstable angina (defined as angina with a progressive increase in symptoms, new onset at rest or nocturnal angina)
- Systemic or local infection that may increase the risk of endovascular graft infection
- Baseline creatinine greater than 2.0 mg/dL
- Can be treated in accordance with the instructions for use with a legally marketed endovascular prosthesis
- Is eligible for enrollment in a manufacturer-sponsored IDE at the investigational site
- Unwilling to comply with the follow-up schedule
- Inability or refusal to give informed consent by subject or legal representative
- Subject is pregnant or breastfeeding
- Ruptured aneurysms
- Uncorrectable coagulopathy
- Body habitus that would inhibit x-ray visualization of the aorta or exceed the safe capacity of the equipment
- Thrombus or excessive calcification within the neck of the aneurysm
- Branch stenosis >50% not amenable to endovascular preparation
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- Mayo ClinicJacksonville, Egyesült ÁllamokContact: Pia GeisselmaierRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The purpose of this research is to assess safety and preliminary effectiveness of the Physician-Modified Terumo Treo Abdominal Stent-Graft System.
A vizsgálat csoportja
- Abdominal aortic aneurysm repairA vizsgált kezelés
Kezelés: Physician-Modified Terumo Treo Abdominal Stent-Graft System
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. július 13.